News

ACP First-Line Recommendation: What Semaglutide's New Clinical Guidelines Mean for Your Weight Loss Protocol
The ACP now lists semaglutide as first-line pharmacotherapy for obesity. What does this mean for weight-loss protocols, and where do other metabolic peptides fit? Read more...